Press Releases

Aegea Biotechnologies, Inc. Advances to Semi-Finals of the $5M XPRIZE Rapid COVID Testing Competition Aegea Biotechnologies' New, Highly Sensitive PCR-based COVID-19 Assay Utilizing Patented Switch-Blocker Technology Advances in the Global XPRIZE Competition Seeking "Faster, Cheaper, and Easier-to-Use COVID-19 Testing Methods at Scale" PR Newswire SAN DIEGO, Sept. 14,...

Read More

This Innovative New Product Offering to be Exclusively Available on the Company’s E-Commerce Platform (www.taurigum.com) New York, NY, Sept. 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line...

Read More